(L-R) Dr Romain Nati (CHL); Dr Gregor Baertz (LIH); Claude Meisch, Minister for Higher Education & Research; Prof. Ulf Nehrbass (LIH); HRH Prince Guillaume; Franz Fayot, Minister of the Economy; Paul Mousel (CHL);
Credit: © SIP / Jean-Christophe Verhaegen
On Tuesday 20 June 2023, His Royal Highness Prince Guillaume, Hereditary Grand Duke of Luxembourg, together with the Minister of the Economy, Franz Fayot, and the Minister for Higher Education and Research, Claude Meisch, visited the LCTR Fuerschungsklinik Lëtzebuerg.
Co-managed by the Centre Hospitalier de Luxembourg (CHL) and the Luxembourg Institute of Health (LIH), in close cooperation with Hôpitaux Robert Schuman (HRS) and the Centre Hospitalier Emile Mayrisch (CHEM), the LCTR (Luxembourg clinical and translational research centre) Fuerschungsklinik is the first national research infrastructure bringing together clinicians, researchers and patients with the aim of translating research findings into tangible therapeutic and diagnostic solutions.
The centre, which opened its doors in December 2022, brings together cutting-edge research infrastructure, medical equipment and administrative and project management support from the CHL Research Unit and the LIH Translational Medicine Operations Hub (TMOH).
The recent guided visit began with welcome speeches by Dr Romain Nati (CEO of CHL) and Dr Ulf Nehrbass (CEO of LIH), who emphasised the economic impact of this and other research infrastructures in Luxembourg, as well as the promotion of research in the Grand Duchy.
More specifically, Dr Hermann Thien, Director of TMOH, and Dr Manon Gantenbein, Head for the LIH Clinical and Epidemiological Investigation Centre (CIEC), presented the services that platforms and infrastructures such as the LCTR, TMOH and CIEC can provide to support the setup and implementation of international clinical trials in Luxembourg.
Moreover, Dr Guy Fagherazzi, Director of the LIH Department of Precision Health, addressed a key topic in digital health, namely the societal impact of research on digital vocal biomarkers and artificial intelligence on patient monitoring.
Finally, Prof. Rejko Krüger, Director of Transversal Translational Medicine (TTM) at LIH, illustrated how clinical research can be translated into personalised digital health solutions to tackle the increasingly relevant burden of neurodegenerative disorders in an ageing society.
The LCTR Fuerschungsklinik Lëtzebuerg is financed by Luxembourg's Ministry of Higher Education and Research and receives financial support from the European Regional Development Fund (ERDF), which is managed by Luxembourg's Ministry of the Economy.
